Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

400-C, new FPTase inhibitor reported by Schering-Plough

Nov. 20, 1996

FPTase inhibitior series reported by Schering-Plough

Nov. 20, 1996

Fujisawa describes new agents for thrombocytopenia

Nov. 20, 1996

New farnesyl protein transferase series synthesized at Merck & Co.

Nov. 20, 1996

Cysteine protease inhibitors revealed by Takeda

Nov. 19, 1996

Hycamtin approved in Europe

Nov. 19, 1996

Antineoplastic PTP inhibitors disclosed by Department of Health & Human Services

Nov. 19, 1996

RCT reports novel circular oligonucleotides

Nov. 19, 1996

NO donors reported for cancer chemotherapy

Nov. 19, 1996

NIH awards grant for gene therapy approach to improving cancer treatment

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 17, 2025
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...